1. Parfejevs, V., et al. Injury-activated glial cells promote wound healing of the adult skin in mice. Nat Commun 9, 236 (2018).
2. Gurtner, G.C., Werner, S., Barrandon, Y. & Longaker, M.T. Wound repair and regeneration. Nature 453, 314-321 (2008).
3. Lebonvallet, N., Laverdet, B., Misery, L., Desmouliere, A. & Girard, D. New insights into the roles of myofibroblasts and innervation during skin healing and innovative therapies to improve scar innervation. Exp Dermatol 27, 950-958 (2018).
4. Yang, R., Wang, J., Chen, X., Shi, Y. & Xie, J. Epidermal Stem Cells in Wound Healing and Regeneration. Stem Cells Int 2020, 9148310 (2020).
5. Ashrafi, M., Baguneid, M. & Bayat, A. The Role of Neuromediators and Innervation in Cutaneous Wound Healing. Acta Derm Venereol 96, 587-594 (2016).
6. Chen, J.C., et al. NGF accelerates cutaneous wound healing by promoting the migration of dermal fibroblasts via the PI3K/Akt-Rac1-JNK and ERK pathways. Biomed Res Int 2014, 547187 (2014).
7. Cheret, J., Lebonvallet, N., Carre, J.L., Misery, L. & Le Gall-Ianotto, C. Role of neuropeptides, neurotrophins, and neurohormones in skin wound healing. Wound Repair Regen 21, 772-788 (2013).
8. Douglas, H.E. TGF-ß in wound healing: a review. J Wound Care 19, 403-406 (2010).
9. Hemmati, A.A., Mojiri Forushani, H. & Mohammad Asgari, H. Wound healing potential of topical amlodipine in full thickness wound of rabbit. Jundishapur J Nat Pharm Prod 9, e15638 (2014).
10. Ashkani-Esfahani, S., et al. Verapamil, a Calcium-Channel Blocker, Improves the Wound Healing Process in Rats with Excisional Full-Thickness Skin Wounds Based on Stereological Parameters. Adv Skin Wound Care 29, 271-274 (2016).
11. Bhaskar, H.N., Udupa, S.L. & Udupa, A.L. Effect of nifedipine and amlodipine on wound healing in rats. Indian J Physiol Pharmacol 48, 111-114 (2004).
12. Bagheri, M., et al. Azelnidipine, a new calcium channel blocker, promotes skin wound healing in diabetic rats. J Surg Res 169, e101-107 (2011).
13. Tseng, K.C., et al. 4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury. EMBO Mol Med 8, 1409-1420 (2016).
14. Yue, L., et al. 4-Aminopyridine attenuates muscle atrophy after sciatic nerve crush injury in mice. Muscle Nerve 60, 192-201 (2019).
15. Noble, M., Tseng, K.C., Li, H.Y. & Elfar, J.C. 4-Aminopyridine as a Single Agent Diagnostic and Treatment for Severe Nerve Crush Injury. Military Medicine 184, 379-385 (2019).
16. Manoukian, O.S., Arul, M.R., Rudraiah, S., Kalajzic, I. & Kumbar, S.G. Aligned microchannel polymer-nanotube composites for peripheral nerve regeneration: Small molecule drug delivery. J Control Release 296, 54-67 (2019).
17. Hayes, K.C. The use of 4-aminopyridine (fampridine) in demyelinating disorders. CNS Drug Rev 10, 295-316 (2004).
18. Hu, D., Liu, J., Keblesh, J. & Xiong, H. Involvement of the 4-aminopyridine-sensitive transient A-type K+ current in macrophage-induced neuronal injury. Eur J Neurosci 31, 214-222 (2010).
19. Li, L., et al. Potentiation of high voltage-activated calcium channels by 4-aminopyridine depends on subunit composition. Mol Pharmacol 86, 760-772 (2014).
20. Bever, C.T. & Judge, S.I. Sustained-release fampridine for multiple sclerosis. Expert Opin Investig Drugs 18, 1013-1024 (2009).
21. Chen, L., Mirza, R., Kwon, Y., DiPietro, L.A. & Koh, T.J. The murine excisional wound model: Contraction revisited. Wound Repair Regen 23, 874-877 (2015).
22. Yeh, C.J., et al. The effects of artocarpin on wound healing: in vitro and in vivo studies. Sci Rep 7, 15599 (2017).
23. Goodman, A.D., et al. Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology 71, 1134-1141 (2008).
24. Suvik, A. & M., E.A.W. The use of modified Masson’s trichrome staining in collagen evaluation in wound healing study. Malaysian Journal of Veterinary Research (Malaysia), 39-47 (2016).
25. Stratton, J.A., et al. Purification and Characterization of Schwann Cells from Adult Human Skin and Nerve. Eneuro 4(2017).
26. Mcheik, J.N., et al. Foreskin-isolated keratinocytes provide successful extemporaneous autologous paediatric skin grafts. J Tissue Eng Regen M 10, 252-260 (2016).
27. Jagadeeshaprasad, M.G., Govindappa, P.K., Nelson, A.M. & Elfar, J.C. Isolation, Culture, and Characterization of Primary Schwann Cells, Keratinocytes, and Fibroblasts from Human Foreskin. JoVE, e63776 (2022).
28. Henrot, P., et al. A Method for Isolating and Culturing Skin Cells: Application to Endothelial Cells, Fibroblasts, Keratinocytes, and Melanocytes From Punch Biopsies in Systemic Sclerosis Skin. Front Immunol 11, 566607 (2020).
29. Gostynska, N., et al. The pleiotropic molecule NGF regulates the in vitro properties of fibroblasts, keratinocytes, and endothelial cells: implications for wound healing. Am J Physiol-Cell Ph 318, C360-C371 (2020).
30. Riis, S., et al. Hypoxia enhances the wound-healing potential of adipose-derived stem cells in a novel human primary keratinocyte-based scratch assay. Int J Mol Med 39, 587-594 (2017).
31. Bei, F., et al. Restoration of Visual Function by Enhancing Conduction in Regenerated Axons. Cell 164, 219-232 (2016).
32. Ito, M., et al. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 447, 316-320 (2007).
33. Nelson, A.M., et al. dsRNA Released by Tissue Damage Activates TLR3 to Drive Skin Regeneration. Cell Stem Cell 17, 139-151 (2015).
34. Santos, M., Paramio, J.M., Bravo, A., Ramirez, A. & Jorcano, J.L. The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis. J Biol Chem 277, 19122-19130 (2002).
35. Bose, A., Teh, M.T., Mackenzie, I.C. & Waseem, A. Keratin k15 as a biomarker of epidermal stem cells. Int J Mol Sci 14, 19385-19398 (2013).
36. Tong, X. & Coulombe, P.A. Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev 20, 1353-1364 (2006).
37. Shwartz, Y., et al. Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells. Cell 182, 578-593 e519 (2020).
38. Dietrich, M., et al. Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis. Brain 143, 1127-1142 (2020).
39. Wallengren, J., Chen, D. & Sundler, F. Neuropeptide-containing C-fibres and wound healing in rat skin. Neither capsaicin nor peripheral neurotomy affect the rate of healing. Br J Dermatol 140, 400-408 (1999).
40. Johnston, A.P., et al. Dedifferentiated Schwann Cell Precursors Secreting Paracrine Factors Are Required for Regeneration of the Mammalian Digit Tip. Cell Stem Cell 19, 433-448 (2016).
41. Peleshok, J.C. & Ribeiro-da-Silva, A. Neurotrophic factor changes in the rat thick skin following chronic constriction injury of the sciatic nerve. Mol Pain 8, 1 (2012).
42. Motohashi, T., et al. Sox10 Functions as an Inducer of the Direct Conversion of Keratinocytes Into Neural Crest Cells. Stem Cells and Development 29, 1510-1519 (2020).
43. Fujiwara, S., et al. SOX10 transactivates S100B to suppress Schwann cell proliferation and to promote myelination. PLoS One 9, e115400 (2014).
44. Bremer, M., et al. Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia 59, 1022-1032 (2011).
45. Matsuda, H., et al. Role of nerve growth factor in cutaneous wound healing: Accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 187, 297-306 (1998).
46. Wilfong, E.R. & Dey, R.D. Nerve growth factor and substance P regulation in nasal sensory neurons after toluene diisocyanate exposure. Am J Resp Cell Mol 30, 793-800 (2004).
47. Paus, R., Luftl, M. & Czarnetzki, B.M. Nerve Growth-Factor Modulates Keratinocyte Proliferation in Murine Skin Organ-Culture. Brit J Dermatol 130, 174-180 (1994).
48. Skoff, A.M. & Adler, J.E. Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors. Exp Neurol 197, 430-436 (2006).
49. Kumar, S., Tan, Y.Y. & Berthiaume, F. Neuropeptide Substance P Enhances Skin Wound Healing In Vitro and In Vivo under Hypoxia. Biomedicines 9(2021).
50. Pastar, I., et al. Epithelialization in Wound Healing: A Comprehensive Review. Adv Wound Care (New Rochelle) 3, 445-464 (2014).
51. Grimaldi, M., Atzori, M., Ray, P. & Alkon, D.L. Mobilization of calcium from intracellular stores, potentiation of neurotransmitter-induced calcium transients, and capacitative calcium entry by 4-aminopyridine. J Neurosci 21, 3135-3143 (2001).
52. Wu, Z.Z., Li, D.P., Chen, S.R. & Pan, H.L. Aminopyridines Potentiate Synaptic and Neuromuscular Transmission by Targeting the Voltage-activated Calcium Channel beta Subunit. Journal of Biological Chemistry 284, 36453-36461 (2009).
53. Dietrich, M., Hartung, H.P. & Albrecht, P. Neuroprotective Properties of 4-Aminopyridine. Neurol-Neuroimmunol 8(2021).
54. Hansebout, R.R., Blight, A.R., Fawcett, S. & Reddy, K. 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. J Neurotrauma 10, 1-18 (1993).
55. Lundh, H., Nilsson, O. & Rosen, I. Effects of 4-aminopyridine in myasthenia gravis. J Neurol Neurosurg Psychiatry 42, 171-175 (1979).
56. Hsu, C.G., et al. Human equivalent dose of oral 4-aminopyridine differentiates nerve crush injury from transection injury and improves post-injury function in mice. Neural Regen Res 15, 2098-2107 (2020).
57. Kasatkina, L.A. 4-aminopyridine sequesters intracellular Ca(2+) which triggers exocytosis in excitable and non-excitable cells. Sci Rep 6, 34749 (2016).
58. Strupp, M., et al. Aminopyridines for the treatment of neurologic disorders. Neurol Clin Pract 7, 65-76 (2017).
59. Wulff, H., Castle, N.A. & Pardo, L.A. Voltage-gated potassium channels as therapeutic targets. Nat. Reviews Drug Disc. 8, 982-1001 (2009).
60. Zhang, W., Das, P., Kelangi, S. & Bei, M. Potassium channels as potential drug targets for limb wound repair and regeneration. Precis Clin Med 3, 22-33 (2020).